Inventor

Alan David Borthwick

Inventor

London, GB

Overview

29→

Patents

1985–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 29 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds39%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%

A61KPreparations for medical, dental or toiletry purposes16%

C07KPeptides4%

C07CAcyclic or carbocyclic compounds3%

C07BGeneral methods of organic chemistry1%

C07HSugars1%

PatentTitleYear

10,870,644Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-l,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation2020 10,752,616Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARb) agonists2020 10,385,044Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARb) agonists2019 9,994,559Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARb) agonists2018 9,447,028'Therapeutic aryl-amido-aryl compounds and their use'2016 9,408,851'Compounds'2016 8,742,099'Compounds'2014 8,541,579'Substituted diketopiperazines as oxytocin antagonists'2013 8,367,673'Substituted diketopiperazines as oxytocin antagonists'2013 8,202,864'Compounds'2012 7,919,492'Compounds'2011 7,550,462'Piperazinediones as oxytocin receptor antagonists'2009 7,514,437'Substituted diketopiperazines as oxytocin antagonists'2009 7,482,374'Pyrrolidine-2-ones as Factor Xa inhibitors'2009 7,329,685'1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor Xa inhibitors for the treatment of acute vascular diseases'2008 7,235,544'3-sulfonylamino-pyrrolidine-2-one derivatives as inhibitors of factor Xa'2007 7,179,835'2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors'2007 5,162,345'Heterocyclic compounds and their preparation and pharmaceutical formulation'1992 5,155,112'Cyclopentane derivatives'1992 5,100,896'Carbocyclic analogues of 7H-1,2,3-triazolo [4,5-d]pyrimidine furanosides'1992 5,091,395'Heterocyclic compounds and their pharmaceutical formulation'1992 5,051,432'Heterocyclic 1,4 dihydropyridine derivatives'1991 4,963,571'Pyridinedicarboxylic acid derivatives and pharmaceutical compositions'1990 4,946,851'1.4-dihydropyridines'1990 4,935,548'1.4-dihydropyridines'1990 4,880,801'Heterocyclic amino compounds'1989 4,806,533'1,4-Dihydro pyridine 3,5 dicarboxylic acid derivatives and compositions'1989 4,769,367'Heterocyclic amino compounds'1988 4,496,579'Benzodioxinopyrrole derivatives and processes for their preparation'1985

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1985–2016Patents assigned to GLAXO GROUP LTD (16)· patent assignee history

1985–2020Based in London, GB· patent location history

1989–1992Patents assigned to GLAXO SPA (7)· patent assignee history

2007–2016Based in Stevenage, GB· patent location history

2012–2013Patents assigned to BORTHWICK ALAN DAVID (2)· patent assignee history

2012–2013Patents assigned to HICKEY DEIRDRE MARY BERNADETTE (2)· patent assignee history

2016–2020Patents assigned to KING S COLLEGE LONDON (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
GLAXO GROUP LTD	16	1985–2016
GLAXO SPA	7	1989–1992
KING S COLLEGE LONDON	5	2016–2020
BORTHWICK ALAN DAVIDself	2	2012–2013
HICKEY DEIRDRE MARY BERNADETTE	2	2012–2013

Locations

Location	Patents	Span
London, GB	17	1985–2020
Stevenage, GB	12	2007–2016